KLK7
Kallikrein-7
Also known as: KLK7_HUMAN, PRSS6, SCCE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49862
- Gene
- KLK7
- Ensembl
- ENSG00000169035
- Chromosome
- 19
- Canonical length
- 253 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nuclear membrane,Plasma membrane
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
This gene encodes a member of the kallikrein subfamily of serine proteases. These enzymes have diverse physiological functions and many kallikrein genes are biomarkers for cancer. The encoded protein has chymotrypsin-like activity and plays a role in the proteolysis of intercellular cohesive structures that precedes desquamation, the shedding of the outermost layer of the epidermis. The encoded protein may play a role in cancer invasion and metastasis, and increased expression of this gene is associated with unfavorable prognosis and progression of several types of cancer. Polymorphisms in this gene may play a role in the development of atopic dermatitis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, which is one of fifteen kallikrein subfamily members located in a gene cluster on chromosome 19. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
253 residues, UniProt reviewed canonical sequence.
>P49862|KLK7
1 MARSLLLPLQ ILLLSLALET AGEEAQGDKI IDGAPCARGS HPWQVALLSG NQLHCGGVLV
61 NERWVLTAAH CKMNEYTVHL GSDTLGDRRA QRIKASKSFR HPGYSTQTHV NDLMLVKLNS
121 QARLSSMVKK VRLPSRCEPP GTTCTVSGWG TTTSPDVTFP SDLMCVDVKL ISPQDCTKVY
181 KDLLENSMLC AGIPDSKKNA CNGDSGGPLV CRGTLQGLVS WGTFPCGQPN DPGVYTQVCK
241 FTKWINDTMK KHRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KLK7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 189 nTPM
Expression across tissuesHPA
Tissue
- skin: 189 nTPM
- esophagus: 91 nTPM
- cervix: 41 nTPM
- vagina: 30 nTPM
- salivary gland: 21 nTPM
- amygdala: 16 nTPM
Single-cell type
- esophageal apical cells: 1,071 nCPM
- salivary duct cells: 307 nCPM
- esophageal suprabasal cells: 151 nCPM
- salivary acinar cells: 71 nCPM
- salivary basal cells: 55 nCPM
- breast secretory cells: 45 nCPM
Immune cell
- basophil: 0.2 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 19 nTPM
- amygdala: 18 nTPM
- hypothalamus: 14 nTPM
- hippocampal formation: 12 nTPM
- pons: 10 nTPM
- basal ganglia: 8.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.03
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antibacterial peptide biosynthetic process
- epidermis development
- extracellular matrix disassembly
- protein maturation
- proteolysis
Molecular functions
- metalloendopeptidase activity
- peptidase activity
- serine-type endopeptidase activity
- serine-type peptidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KLK7 as an antibody target. Whether an autoantibody or antibody against KLK7 could matter depends on whether native KLK7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KLK7 is annotated at the cell surface, where native KLK7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KLK7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...